114
Participants
Start Date
January 4, 2016
Primary Completion Date
May 6, 2022
Study Completion Date
June 15, 2022
Supervised Treadmill Exercise Therapy
Participants randomized to the exercise intervention will receive supervised treadmill exercise three times weekly for six months.
Telmisartan
Participants randomized to the telmisartan arm of the study will take 20 mg or 40 mg of telmisartan daily based on the results of their study run-in. Participants will have their dose increased to up to 80 mg as tolerated.
"No exercise control group"
Participants randomized to the attention control group will attend weekly one-hour educational sessions at Northwestern University for six months.
Placebo
Northwestern University, Chicago
Tulane University, New Orleans
Ochsner Medical Center, New Orleans
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Northwestern University
OTHER